Cargando…
Simiao Wan and its ingredients alleviate type 2 diabetes mellitus via IRS1/AKT2/FOXO1/GLUT2 signaling
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a metabolic disease. Simiao Wan (SMW) is a commonly used clinical drug for hyperuricemia treatment. SMW has been confirmed to improve insulin resistance and is expected to be a novel hypoglycemic agent. However, the hypoglycemic bioactive ingredients an...
Autores principales: | Xia, Ting, Xu, Wen-Jie, Hu, Yan-Nan, Luo, Zhen-Ye, He, Wen, Liu, Chang-Shun, Tan, Xiao-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868910/ https://www.ncbi.nlm.nih.gov/pubmed/36698459 http://dx.doi.org/10.3389/fnut.2022.1012961 |
Ejemplares similares
-
Simiao Decoction Alleviates Gouty Arthritis by Modulating Proinflammatory Cytokines and the Gut Ecosystem
por: Lin, Xiaoying, et al.
Publicado: (2020) -
Identification of the Chemical Constituents in Simiao Wan and Rat Plasma after Oral Administration by GC-MS and LC-MS
por: Fan, Yunshuang, et al.
Publicado: (2017) -
Dietary supplementation of inulin alleviates metabolism disorders in gestational diabetes mellitus mice via RENT/AKT/IRS/GLUT4 pathway
por: Miao, Miao, et al.
Publicado: (2021) -
Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1–PI3K–AKT signaling pathway and GLUT4 expression
por: Guo, Xuan, et al.
Publicado: (2019) -
Editorial: Functional Foods and Bioactive Food Ingredients in Prevention and Alleviation of Metabolic Syndrome
por: Torres, Sebastian, et al.
Publicado: (2021)